GlucoTrack Inc. (GCTK)
0.16
-0.00 (-2.44%)
At close: Apr 17, 2025, 3:59 PM
-2.44% (1D)
| Bid | 0.15 |
| Market Cap | 4.07M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -22.6M |
| EPS (ttm) | -68.44 |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.17 |
| Volume | 993,484 |
| Avg. Volume (20D) | 5,164,210 |
| Open | 0.16 |
| Previous Close | 0.16 |
| Day's Range | 0.15 - 0.16 |
| 52-Week Range | 0.13 - 99.00 |
| Beta | 0.02 |
About GCTK
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its na...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Apr 25, 2013
Employees 11
Stock Exchange NASDAQ
Ticker Symbol GCTK
Website https://www.glucotrack.com
2 months ago
-28.95%
Glucotrack shares are trading lower after the comp...
Unlock content with
Pro Subscription
2 months ago
+2.19%
GlucoTrack shares are trading higher. The company announced it appointed Peter Wulff As CFO.
